The FDA late Friday approved the first coronavirus test that can be conducted entirely at the point of care for a patient — and deliver results in 45 minutes
on health-care facilities by helping doctors find out quickly whether a patient has the disease and select the appropriate treatment.“This is not a test for the worried well,” he said, but rather a tool for doctors to quickly assess patients suspected of having covid-19.
The specimen can be collected either by a nasal swab or by a saline wash using a small catheter. Neither is particularly comfortable, but the advantage of the wash is that itSign up for our Coronavirus Updates newsletter to track the outbreak. All stories linked in the newsletter are free to access.To further ease pressure on hospitals, the administration has said it is exploring at-home test kits. But so far, theit has not approved any testing at home.
William Jaquis, president of the American College of Emergency Physicians, said the newly authorized test could be “extremely helpful” by reducing delays in getting results.But he said the key to how much benefit a test like this provides depends on “how accurate it is on both positive and the negative” results.
The test, like Cepheid’s existing strep and flu tests, does not require confirmatory tests, Persing said.The coronavirus test is designed to operate on the company’s automated GeneXpert Systems. There are about 23,000 of those systems throughout the world, of which 5,000 are in the United States, according to the company.
The firm plans to begin selling the test at the end of the month. Persing declined to say how many tests initially will be produced but said the goal is to make millions in the next few months.The Washington Post is providing some coronavirus coverage free, including:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA approves new test that could detect coronavirus in about 45 minutesThe FDA announced its approval of the use of the first rapid diagnostic test that could detect coronavirus in approximately 45 minutes. Authorization was made Friday and tests will begin shipping next week, according to the company manufacturing the tests
Baca lebih lajut »
FDA grants 'emergency use' coronavirus test that can deliver results in 45 minutesCepheid has received emergency authorization from the Food and Drug Administration to use its rapid molecular test for point-of-care patients that can detect coronavirus in 45 minutes. This is the first coronavirus that can be conducted entirely at the point of care for patients and deliver results in less than an hour. Tests are typically sent to central reference labs that can take several days to deliver results.
Baca lebih lajut »
FDA Approves First Rapid 'Point-Of-Care' Coronavirus Test That Can Give Results in 45 MinutesThe tests will begin to ship next week with plans of using the product by the end of the month
Baca lebih lajut »
FDA approves first rapid coronavirus test with 45 minutes detection timeThe U.S. Food and Drug Administration has approved the first rapid coronavirus d...
Baca lebih lajut »
FDA: Those who donate blood 'are contributing immeasurably'The FDA is urging Americans to donate blood, saying those who do 'are contributing immeasurably to the public health of our nation.'
Baca lebih lajut »